Cargando…

2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease

A hallmark of Parkinson’s disease is the formation of large protein-rich aggregates in neurons, where α-synuclein is the most abundant protein. A standard approach to visualize aggregation is to fluorescently label the proteins of interest. Then, highly fluorescent regions are assumed to contain agg...

Descripción completa

Detalles Bibliográficos
Autores principales: Camacho, Rafael, Täuber, Daniela, Hansen, Christian, Shi, Juanzi, Bousset, Luc, Melki, Ronald, Li, Jia-Yi, Scheblykin, Ivan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168587/
https://www.ncbi.nlm.nih.gov/pubmed/30302401
http://dx.doi.org/10.1038/s42003-018-0156-x
_version_ 1783360381102587904
author Camacho, Rafael
Täuber, Daniela
Hansen, Christian
Shi, Juanzi
Bousset, Luc
Melki, Ronald
Li, Jia-Yi
Scheblykin, Ivan G.
author_facet Camacho, Rafael
Täuber, Daniela
Hansen, Christian
Shi, Juanzi
Bousset, Luc
Melki, Ronald
Li, Jia-Yi
Scheblykin, Ivan G.
author_sort Camacho, Rafael
collection PubMed
description A hallmark of Parkinson’s disease is the formation of large protein-rich aggregates in neurons, where α-synuclein is the most abundant protein. A standard approach to visualize aggregation is to fluorescently label the proteins of interest. Then, highly fluorescent regions are assumed to contain aggregated proteins. However, fluorescence brightness alone cannot discriminate micrometer-sized regions with high expression of non-aggregated proteins from regions where the proteins are aggregated on the molecular scale. Here, we demonstrate that 2-dimensional polarization imaging can discriminate between preformed non-aggregated and aggregated forms of α-synuclein, and detect increased aggregation in brain tissues of transgenic mice. This imaging method assesses homo-FRET between labels by measuring fluorescence polarization in excitation and emission simultaneously, which translates into higher contrast than fluorescence anisotropy imaging. Exploring earlier aggregation states of α-synuclein using such technically simple imaging method could lead to crucial improvements in our understanding of α-synuclein-mediated pathology in Parkinson’s Disease.
format Online
Article
Text
id pubmed-6168587
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61685872018-10-09 2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease Camacho, Rafael Täuber, Daniela Hansen, Christian Shi, Juanzi Bousset, Luc Melki, Ronald Li, Jia-Yi Scheblykin, Ivan G. Commun Biol Article A hallmark of Parkinson’s disease is the formation of large protein-rich aggregates in neurons, where α-synuclein is the most abundant protein. A standard approach to visualize aggregation is to fluorescently label the proteins of interest. Then, highly fluorescent regions are assumed to contain aggregated proteins. However, fluorescence brightness alone cannot discriminate micrometer-sized regions with high expression of non-aggregated proteins from regions where the proteins are aggregated on the molecular scale. Here, we demonstrate that 2-dimensional polarization imaging can discriminate between preformed non-aggregated and aggregated forms of α-synuclein, and detect increased aggregation in brain tissues of transgenic mice. This imaging method assesses homo-FRET between labels by measuring fluorescence polarization in excitation and emission simultaneously, which translates into higher contrast than fluorescence anisotropy imaging. Exploring earlier aggregation states of α-synuclein using such technically simple imaging method could lead to crucial improvements in our understanding of α-synuclein-mediated pathology in Parkinson’s Disease. Nature Publishing Group UK 2018-10-02 /pmc/articles/PMC6168587/ /pubmed/30302401 http://dx.doi.org/10.1038/s42003-018-0156-x Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Camacho, Rafael
Täuber, Daniela
Hansen, Christian
Shi, Juanzi
Bousset, Luc
Melki, Ronald
Li, Jia-Yi
Scheblykin, Ivan G.
2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
title 2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
title_full 2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
title_fullStr 2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
title_full_unstemmed 2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
title_short 2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
title_sort 2d polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168587/
https://www.ncbi.nlm.nih.gov/pubmed/30302401
http://dx.doi.org/10.1038/s42003-018-0156-x
work_keys_str_mv AT camachorafael 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT tauberdaniela 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT hansenchristian 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT shijuanzi 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT boussetluc 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT melkironald 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT lijiayi 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease
AT scheblykinivang 2dpolarizationimagingasalowcostfluorescencemethodtodetectasynucleinaggregationexvivoinmodelsofparkinsonsdisease